Cargando…

Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China

BACKGROUND: Hepatitis B surface antigen (HBsAg) clearance is vital for a functional cure of hepatitis B virus (HBV) infection. However, the incidence and predictors of HBsAg seroclearance in patients co-infected with HBV and human immunodeficiency virus (HIV) remain largely unknown in Guangdong, Chi...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yaozu, Lin, Weiyin, Li, Hong, Gu, Fei, Zhong, Huolin, Lan, Yun, Li, Yonghong, Guo, Pengle, Hu, Fengyu, Cai, Weiping, Tang, Xiaoping, Li, Linghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684156/ https://www.ncbi.nlm.nih.gov/pubmed/37881959 http://dx.doi.org/10.1097/CM9.0000000000002886

Ejemplares similares

Early on-treatment plasma interleukin-18 as a promising indicator for long-term virological response in patients with HIV-1 infection
por: Lin, Weiyin, et al.
Publicado: (2023)

The Association of TLR2, TLR3, and TLR9 Gene Polymorphisms With Susceptibility to Talaromycosis Among Han Chinese AIDS Patients in Guangdong
por: Wang, Min, et al.
Publicado: (2021)

Transcriptome analysis of CD4(+) T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity
por: Chen, Jingliang, et al.
Publicado: (2023)

Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China
por: Lin, Weiyin, et al.
Publicado: (2022)

Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
por: Lan, Yun, et al.
Publicado: (2020)

Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection
por: Cao, Jing, et al.
Publicado: (2020)

Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
por: Lee, Hyun Woong, et al.
Publicado: (2020)

Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China
por: Lan, Yun, et al.
Publicado: (2022)

Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
por: Lan, Yun, et al.
Publicado: (2021)

Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective
por: Nie, Yuan, et al.
Publicado: (2020)

The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023)

Using Machine Learning Algorithms to Predict Hepatitis B Surface Antigen Seroclearance
por: Tian, Xiaolu, et al.
Publicado: (2019)

Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome
por: Chen, Xiaoman, et al.
Publicado: (2022)

HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014–2019
por: Lan, Yun, et al.
Publicado: (2021)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011–2022: A Retrospective Study
por: Lan, Yun, et al.
Publicado: (2023)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China
por: Deng, Xizi, et al.
Publicado: (2022)

Artificial Neural Network Accurately Predicts Hepatitis B Surface Antigen Seroclearance
por: Zheng, Ming-Hua, et al.
Publicado: (2014)

A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China
por: Lin, Weiyin, et al.
Publicado: (2023)

Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy
por: Liang, Minfeng, et al.
Publicado: (2011)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

Evaluation of HBsAg Seroclearance in Patients with Hepatitis B
por: Taşkın, Mehmet Can, et al.
Publicado: (2022)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018)

Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis
por: Song, Aixin, et al.
Publicado: (2021)

Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
por: Park, Yewan, et al.
Publicado: (2021)

Sex differences in HIV treatment outcomes and adherence by exposure groups among adults in Guangdong, China: A retrospective observational cohort study
por: Li, Linghua, et al.
Publicado: (2020)

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
por: Yu, Haisheng, et al.
Publicado: (2023)

Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma
por: Naimimohasses, Sara, et al.
Publicado: (2017)

Epidemiological, Clinical and Histological Characteristics of HBV/HDV Co-Infection: A Retrospective Cross-Sectional Study in Guangdong, China
por: Liao, Baolin, et al.
Publicado: (2014)

Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients
por: Yeo, Yee Hui, et al.
Publicado: (2020)

Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China
por: Lei, Chunliang, et al.
Publicado: (2020)

Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
por: Kim, Saein, et al.
Publicado: (2021)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B
por: Hui, Ka-Yin, et al.
Publicado: (2023)

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
por: Taniguchi, Hideaki, et al.
Publicado: (2020)

HIV-1 tropism in low-level viral load HIV-1 infections during HAART in Guangdong, China
por: Zhang, Chuyu, et al.
Publicado: (2023)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Critical appraisal and external validation of a prognostic model for survival of people living with HIV/AIDS who underwent antiretroviral therapy
por: Wang, Junfeng, et al.
Publicado: (2020)

Cancer incidence and mortality in Guangdong province, 2012
por: Meng, Ruilin, et al.
Publicado: (2016)

HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection
por: Masrour-Roudsari, Jila, et al.
Publicado: (2020)

Fatal acute-on-chronic liver failure following camrelizumab for hepatocellular carcinoma with HBsAg seroclearance: a case report and literature review
por: Li, Fenghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5fbbt57cdd4hj6hl0ccclt7k89